A month ago, Teslas closing stock price peaked at $383.45, and last week the stock closed below $330.
Tesla Inc. Powerpacks and inverters stand at the Southern California Edison Co. Mira Loma energy storage system facility in Ontario, California, U.S., on Thursday, June 1, 2017. The Mira Loma substation houses nearly 400 Tesla Powerpack units, in an effort to operate to state regulations on producing clean energy electricity. Photographer: Patrick T. Fallon/Bloomberg
Apparently, investors are beginning to catch on to the fact that Tesla CEO Elon Musk has a severe case of a behavioral condition known as the planning fallacy. People who suffer from the planning fallacy are serial offenders when it comes to projects coming in over budget, late, and with fewer features than promised. The New York Times reported that Telsa’s main problematic issues pertain to a slower timetable than expected for the introduction of the Model 3, along with problems that relate to the manufacture of its battery packs.
Best Clean Energy Stocks To Invest In 2019: URS Corporation(URS)
- [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]
Fund manager John Mirshekari, of the Fidelity Low-Priced Stock Fund, recommended shares of URS (URS), an engineering and construction contractor.
- [By Ben Levisohn]
Fidelty’s John Mirshekaritook a look at URS(URS) today at the Value Investing Congress.His takeaway: The stock could double in two years.
Agence France-Presse/Getty Images
His analysis started with URS’s use of its free cash. During the past, it hasn’t been pretty. They spent 6.3 billion on eight acquisitions, they’ve bought companies at valuations higher than own stock and return-on-equity has dropped from high teens to just 6%.
The problem hasn’t been its business: Its return on tangible capital is 17%. Instead, the problem is that its management hasn’t maximized value through capital allocation. URS has lowest valuation: 9x 2013 cash earnings in its industry.
Part of the problem: Management incentives are based on net income. This year, however, relative total shareholder return was added., something Mirshekari calls”a step in the right direction.” In May, URS filed an amended proxy which says it will look to change incentives from net income to return on equity and earnings per share. More importantly, it said acquisitions would end.
If all goes right, URS could double in two years,Mirshekari says, comparing it to AECOM Technology (ACM).
Looks a lot like AECOMM, which did something similar and rallied.
Best Clean Energy Stocks To Invest In 2019: Devon Energy Corporation(DVN)
- [By Matthew DiLallo]
The failure of Russia and others to fulfill their obligations are coming at a time when U.S. shale production is starting to ramp back up. Shale producers such as Pioneer Natural Resources (NYSE:PXD) and Devon Energy (NYSE:DVN) have already released growth-focused budgets to capture the benefits of an improving oil market. In Pioneer Natural Resources’ case, it expects to spend $2.8 billion this year to operate 18 drilling rigs in the Permian Basin and restart its drilling program in the Eagle Ford. Those rigs should enable the company to drill enough wells to grow its production by 15% to 18% over last year’s average. Meanwhile, Devon Energy expects to spend between $2 billion to $2.3 billion on drilling this year, which should fuel 13% to 17% oil production growth by the fourth quarter versus last year’s final quarter.
- [By Paul Ausick]
Devon Energy Corp. (NYSE: DVN) is rated Hold and the price target was raised to $49. The 2017 EPS estimate was increased from $1.39 to $2.00, and the 2018 estimate increased from $3.06 to $3.83. Shares closed at $43.35 on Friday, in a 52-week range of $21.15 to $50.69. No consensus price target was available.
- [By ]
As things stand right now, analysts anticipate that at least some Iranian oil will come off the market as a result of the sanctions. That lost output would further tighten an oil market that suddenly has little margin for error thanks to red-hot demand and tame supply growth. That’s the recipe for higher oil prices and could make top-tier U.S. oil stocks Anadarko Petroleum (NYSE:APC), Devon Energy (NYSE:DVN), and ConocoPhillips (NYSE:COP) big winners in the coming years.
- [By Matthew DiLallo]
Saudi Aramco’s valuation, however, isn’t the only one that would benefit from a pop in the price of crude. Many oil producers in the U.S. restructured their operations to run on $50 oil, so if the Saudi strategy is successful, these oil companies would produce a gusher of cash flow, which could fuel high-octane gains for investors. While that rise would likely lift the entire sector, Devon Energy (NYSE:DVN) and Marathon Oil (NYSE:MRO)could outperform in that scenario.
Best Clean Energy Stocks To Invest In 2019: Triple-S Management Corporation(GTS)
- [By Peter Graham]
Small cap Triple-S Management Corp (NYSE: GTS) is an independent licensee of the Blue Cross Blue Shield Association. It is one of the leading players in the managed care industry in Puerto Rico. Triple-S Management has the exclusive right to use the Blue Cross Blue Shield name and mark throughout Puerto Rico, the U.S. Virgin Islands, and Costa Rica. With more than 50 years of experience in the industry, Triple-S Management offers a broad portfolio of managed care and related products in the Commercial, Medicare Advantage, and Medicaid markets under the Blue Cross Blue Shield marks. It also provides non-Blue Cross Blue Shield branded life and property and casualty insurance in Puerto Rico.
Best Clean Energy Stocks To Invest In 2019: The NeutriSci International (NU)
- [By Matthew Briar]
What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.
Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.
Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.
NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.
Pterostilbene (found in blueberries, by the way) is o
- [By Matthew Briar]
Indeed, it’s also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.
- [By Matthew Briar]
Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).
Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.
It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.
Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.
The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp
Best Clean Energy Stocks To Invest In 2019: AmTrust Financial Services, Inc.(AFSI)
- [By Dan Caplinger]
The stock market kept performing well on Monday, and the Dow Jones Industrials posted its 12th straight all-time record high. Market sentiment was sunny following the release of Warren Buffett’s annual shareholder letter over the weekend, and the Oracle of Omaha made positive comments about the sustainability of the current bull market, which was able to overcome early declines in the major market benchmarks. However, some stocks didn’t fare as well as the overall market, and Tesla (NASDAQ:TSLA), AmTrust Financial Services (NASDAQ:AFSI), and Horizon Pharma (NASDAQ:HZNP) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.
- [By Lisa Levin]
In trading on Friday, financial shares fell 0.24 percent. Meanwhile, top losers in the sector included AmTrust Financial Services Inc (NASDAQ: AFSI), down 18 percent, and GSV Capital Corp (NASDAQ: GSVC), down 9 percent.
- [By Lisa Levin]
In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.
- [By Paul Ausick]
AmTrust Financial Services Inc. (NASDAQ: AFSI) dropped more than 18% Monday, to post a new 52-week low of $22.58 after closing at $27.66 on Friday. The stock’s 52-week high is $28.48. Volume was more than 10 times the daily average of around 670,000 shares. The company missed profit estimates this morning.
- [By Paul Ausick]
AmTrust Financial Services Inc. (NASDAQ: AFSI) dropped about 28% Tuesday to post a new 52-week low of $13.51 after closing Monday at $18.87. The stock’s 52-week high is $28.48. Volume of about 19 million shares was about 9 times the daily average of around 2.1 million. A whistleblower report has resulted in an SEC probe into the company’s accounting practices.